AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH

Early Antiretroviral Therapy Prevents Non-Aids Outcomes in HIV-Infected People, NIH-Supported Study Finds

NIH logo

New Findings Illustrate Manifold Benefit of Therapy Starting antiretroviral therapy early not only prevents serious AIDS-related diseases, but also prevents the onset of cancer, cardiovascular disease, and other non-AIDS-related diseases in HIV-infected people, according to a new analysis of data from the Strategic Timing of AntiRetroviral Treatment (START) study, the first large-scale randomized clinical trial to…

HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus

NIH logo

NIH-Funded Trial Proves Suppressive Antiretroviral Therapy for HIV-infected People Effective in Protecting Uninfected Partners ​Antiretroviral treatment that consistently suppresses HIV is highly effective at preventing sexual transmission of the virus in heterosexual couples where one person is HIV-infected and the other is not, investigators report today at the 8th International AIDS Society Conference on HIV…

Next Week: Video Highlights of HIV Science Presented at IAS 2015

IAS2015_web_logo

The 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) takes place next week in Vancouver, Canada. For those not able to be there in person, NIH’s Dr. Carl Dieffenbach has agreed to offer scientific highlights via video posts here on blog.aids.gov. Dr. Dieffenbach, who is Director of the Division of…

Spotlight on HIV and Aging

lsht_poster_reggie

Next week, the 2015 White House Conference on Aging puts a spotlight on healthy aging. Held each decade since the 1960s, the conference brings together older Americans, caregivers, government officials, and business and community leaders to discuss a vision for healthy aging in the next decade. For many of us, that vision includes healthy aging, support,…

Appreciating Dr. Jack Whitescarver’s Many Contributions to HIV/AIDS Research

photo whitescarver

At the end of this month, we bid a fond farewell to a colleague who has played a key role in leading Federal research efforts in response to HIV/AIDS since the earliest days of the epidemic. As NIH previously announced, on July 1, 2015, Dr. Jack Whitescarver is retiring and stepping down as NIH’s Associate…

Funding Available from NIH’s HIV/AIDS Community Information Outreach Project

NIH_NLM_BLU_VERT_4 (1)

NIH’s National Library of Medicine (NLM) has announced the solicitation of quotations from organizations and libraries to design and conduct projects for improving HIV/AIDS information access for patients and the affected community as well as their caregivers and the general public. Awards of up to $50,000 are available. Applications are due by July 20, 2015….

Curing Hard-to-Treat Hepatitis C

hepc_crop

In a new video, NIH researchers and their colleagues from health centers in the District of Columbia discuss efforts to improve treatments for hepatitis C, a potentially life-threatening viral disease that slowly damages the liver. NIH-sponsored clinical studies in the nation’s capital focus on identifying effective, safe, and convenient therapies for hard-to-treat hepatitis C patients,…

A Conversation with Dr. Anthony Fauci: Results from the START Trial and Implications for the Global Treatment of HIV

Anthony Fauci

Last week, NIH’s National Institute of Allergy and Infectious Diseases (NIAID) released the exciting results of the Strategic Timing of Antiretroviral Treatment (START) study, a randomized, controlled clinical trial to more clearly define the optimal time and benefits for people with HIV to begin antiretroviral therapy (ART). Given the implications of the study, AIDS.gov sat…